Bio Essence Corp (BIOE)

↓ Download CSV

CIK 0001723059 · OTC · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated CA
  • Fiscal year ends Dec 31

In fiscal 2025, Bio Essence Corp reported revenue of $1.90M, up 485.8% from the prior year. The company was profitable, with a net margin of 47.2% and a gross margin of 75.3%. It held $422.5K in total assets against $2.50M in total liabilities.

Key ratios (FY2025)

75.3%
Gross margin
47.4%
Operating margin
47.2%
Net margin
+485.8%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019
Revenue$1.90M$323.9K$551.5K$621.6K$888.0K$958.7K
Cost of Revenue$469.2K$106.9K$274.1K$293.3K$589.7K$731.4K
Gross Profit$1.43M$217.1K$277.4K$328.3K$298.3K$227.3K
Operating Income$900.0K-$459.4K-$345.6K-$511.1K-$857.5K-$832.6K
Net Income$896.2K-$1.31M-$971.9K-$809.7K-$647.6K-$595.8K
EPS (Diluted)$-0.03$-0.03$-0.02$-0.02
Total Assets$422.5K$281.0K$2.76M$1.55M$1.70M$1.85M
Total Liabilities$2.50M$3.25M$4.42M$4.79M$4.13M$3.63M
Shareholders' Equity-$2.07M-$2.97M-$1.66M-$3.24M-$2.43M-$1.78M-$1.09M
Cash & Equivalents$1.4K$114$6.3K$303$5.3K$16.2K
Operating Cash Flow$1.57M$623.9K-$1.03M-$703.2K-$1.29M-$732.7K
Capital Expenditures$3.6K$3.7K$119.5K$7.4K
Shares Outstanding38.01M38.01M38.01M33.01M33.01M33.01M